Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells

被引:0
|
作者
Oshimi, Y
Oda, S
Honda, Y
Nagata, S
Miyazaki, S
机构
[1] TOKYO WOMENS MED COLL, DEPT PHYSIOL, SHINJUKU KU, TOKYO 162, JAPAN
[2] OSAKA UNIV, SCH MED, DEPT GENET, SUITA, OSAKA 565, JAPAN
[3] OSAKA BIOSCI INST, SUITA, OSAKA 565, JAPAN
[4] NATL INST PHYSIOL SCI, DEPT MOL PHYSIOL, LAB INTRACELLULAR METAB, OKAZAKI, AICHI 444, JAPAN
来源
JOURNAL OF IMMUNOLOGY | 1996年 / 157卷 / 07期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cytotoxicity of NK cells has been thought to be mediated mainly by the perforin-dependent pathway. We investigated the involvement of Fas-mediated pathway in the killing activity of purified human CD3(-), CD16(+) NK cells. Fas ligand mRNA was expressed in freshly isolated NK cells. Apoptosis, which was identified by the fragmented chromatin in individual cells, was induced in the cells that expressed high levels of Fas via direct NK-to-target cell interaction or Ab-dependent cell-mediated cytotoxicity, even in Ca2+-free medium, in which perforin pores are known not to be formed. Apoptosis in both the presence and absence of external Ca2+ was inhibited by Fab of an anti-fas mAb. Transfection of the Fas gene in target cells facilitated the induction of apoptosis, compared with the parental cell line. The function of the Fas-mediated pathway in the coexistence of the perforin-dependent pathway was examined in 10 cell lines expressing different levels of Fas by Ca2+ imaging and morphologic observation of single cells. With a certain boundary level, low or high levels of Fas expression in target cells were correlated to a great degree with either acute necrosis due to severe membrane damage after NK-target cell contact or apoptosis at a later period, respectively. We concluded that Fas ligand/Fas interaction is present and plays a significant role in the human NK cell-induced apoptosis.
引用
收藏
页码:2909 / 2915
页数:7
相关论文
共 50 条
  • [21] Fas-mediated apoptosis of hepatic cells
    Feldmann, G
    Lamboley, C
    Moreau, A
    Bringuier, A
    BIOMEDICINE & PHARMACOTHERAPY, 1998, 52 (09) : 378 - 385
  • [22] The Fas-Mediated Apoptotic Pathway in Cardiac Myxoma
    Liu, Cheng-Chung
    Jung, Shih-Ming
    Orlandi, Augusto
    Yeh, Ta-Sen
    Lin, Yu-Shen
    Shiu, Tzu-Fang
    Wu, Hsueh-Hua
    Chu, Jaw-Ji
    Lin, Pyng-Jing
    Chu, Pao-Hsien
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2010, 18 (06) : 493 - 498
  • [23] Autocrine secretion of fas ligand shields tumor cells from fas-mediated killing by cytotoxic lymphocytes
    Hallermalm, K
    De Geer, A
    Kiessling, R
    Levitsky, V
    Levitskaya, J
    CANCER RESEARCH, 2004, 64 (18) : 6775 - 6782
  • [24] Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II)
    Mizutani, Y
    Yoshida, O
    Bonavida, B
    JOURNAL OF UROLOGY, 1998, 160 (02): : 561 - 570
  • [25] Inhibition of the MEK signalling pathway potentiates Fas-mediated apoptosis in human T cells
    Walker, LSK
    McLeod, JD
    Hall, ND
    Ward, SG
    Patel, YI
    Sansom, DM
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122
  • [26] Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis
    Xerri, L
    Devilard, E
    Hassoun, J
    Haddad, P
    Birg, F
    LEUKEMIA, 1997, 11 (11) : 1868 - 1877
  • [27] Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action
    Belanger, AJ
    Scaria, A
    Lu, HW
    Sullivan, JA
    Cheng, SH
    Gregory, RJ
    Jiang, CW
    CARDIOVASCULAR RESEARCH, 2001, 51 (04) : 749 - 761
  • [28] Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity
    Matter-Reissmann, UB
    Sonntag, KC
    Gilli, UO
    Leguern, C
    Schneider, MKJ
    Seebach, JD
    XENOTRANSPLANTATION, 2004, 11 (01) : 43 - 52
  • [29] Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis
    L Xerri
    E Devilard
    J Hassoun
    P Haddad
    F Birg
    Leukemia, 1997, 11 : 1868 - 1877
  • [30] Involvement of caspase-4(-like) protease in Fas-mediated apoptotic pathway
    Kamada, S
    Washida, M
    Hasegawa, J
    Kusano, H
    Funahashi, Y
    Tsujimoto, Y
    ONCOGENE, 1997, 15 (03) : 285 - 290